✦ LIBER ✦

Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group

✍ Scribed by A. P. M. van der Meijden; Karl-Heinz Kurth; Wim Oosterlinck; Frans M. J. Debruyne

Publisher: Springer
Year: 1992
Tongue: English
Weight: 387 KB
Volume: 30
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00686952

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravesical instillation therapy with A

Intravesical instillation therapy with Adriamycin for bladder cancer in the Korean study group

✍ S. K. Kim; H. J. An; J. H. Cho 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 201 KB

Long-term results of intravesical chemop

Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese urological cancer research group for Adriamycin

✍ Hideyuki Akaza; Kenkichi Koiso; Toshihiko Kotake; Yosuke Matsumura; Shigeo Isaka 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 570 KB

The 4th study of prophylactic intravesic

The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin

✍ Yosuke Matsumura; Hideyuki Akaza; Shigeo Isaka; Susumu Kagawa; Kenkichi Koiso; T 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 397 KB

Intravesical 4′-epi-doxorubicin(epirubic

Intravesical 4′-epi-doxorubicin(epirubicin) versus bacillus calmette—guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer

✍ Michael D. Melekos; Heracles S. Chionis; George S. Paranychianakis; Houssam H. D 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

Background. The selection of the most appropriate antineoplastic agent and optimal treatment schedule for the prophylaxis of superficial bladder cancer against tumor recurrences is the subject of continual investigations. Methods. A controlled prospective trial involving 161 patients evaluated and

Phase III trial of The Japanese Urologic

Phase III trial of The Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder

✍ Akio Maru; Hideyuki Akaza; Shigeo Isaka; Kenkichi Koiso; Toshihiko Kotake; Toyoh 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 489 KB

Intravesical chemotherapy for maximum pr

Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection : A combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function

✍ Shiro Hinotsu; Hideyuki Akaza; Yasuo Ohashi; Toshihiko Kotake 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## BACKGROUND. The effect of intravesical instillation of doxorubicin or epirubicin after transurethral resection (TUR) was estimated from the data of five randomized clinical trials in Japan. The authors provided the estimated hazard function plots with a smoothing technique, to evaluate the prop